These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of a perindopril-based blood-pressure-lowering regimen in patients with previous stroke or transient ischaemic attack (progress). How do the results affect practice in Pakistan? Khan M; Kamal AK J Pak Med Assoc; 2010 Jul; 60(7):597-8. PubMed ID: 20578620 [No Abstract] [Full Text] [Related]
4. Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice. Jackson G Int J Clin Pract; 2003 Jun; 57(5):385-7. PubMed ID: 12846342 [TBL] [Abstract][Full Text] [Related]
5. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy. Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116 [TBL] [Abstract][Full Text] [Related]
6. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. Davis SM; Donnan GA N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297 [No Abstract] [Full Text] [Related]
7. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480 [TBL] [Abstract][Full Text] [Related]
8. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. Keenan K; Hayen A; Neal BC; Irwig L BMJ; 2009 Apr; 338():b1492. PubMed ID: 19406886 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hypertension and prevention of ischemic stroke. Aronow WS; Frishman WH Curr Cardiol Rep; 2004 Mar; 6(2):124-9. PubMed ID: 14759357 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients? Schiffrin EL Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782 [No Abstract] [Full Text] [Related]